TipRanks
Advertisement
Advertisement

DE:TTX Stock Latest News

Theralase Narrows Loss and Expands Bladder Cancer Trial with Ferring
Company AnnouncementsTheralase Narrows Loss and Expands Bladder Cancer Trial with Ferring
16d ago
Theralase Launches GLP Toxicology Program for Rutherrin Cancer Therapy
PremiumCompany Announcements
Theralase Launches GLP Toxicology Program for Rutherrin Cancer Therapy
18d ago
Theralase Narrows Loss, Bolsters Cash as Bladder Cancer Trial Advances
PremiumCompany Announcements
Theralase Narrows Loss, Bolsters Cash as Bladder Cancer Trial Advances
1M ago
Theralase Raises C$3.6 Million to Advance Cancer and Antiviral Pipeline
PremiumCompany Announcements
Theralase Raises C$3.6 Million to Advance Cancer and Antiviral Pipeline
1M ago
Theralase launches up to C$5 million LIFE financing to advance cancer and antiviral pipeline
PremiumCompany Announcements
Theralase launches up to C$5 million LIFE financing to advance cancer and antiviral pipeline
2M ago
Theralase Grants 7 Million Stock Options to Advance Growth Plans
PremiumCompany AnnouncementsTheralase Grants 7 Million Stock Options to Advance Growth Plans
2M ago
Premium
Company Announcements
Theralase Posts 100% Preclinical Response in Muscle Invasive Bladder Cancer Study
6M ago
Premium
Company Announcements
Theralase Raises C$2.66 Million to Advance Bladder Cancer Drug Programs
6M ago
PremiumCompany Announcements
Theralase Uncovers New Antiviral Mechanism for Ruvidar Against Herpes Virus
7M ago
PremiumCompany Announcements
Theralase Raises C$1.1 Million to Advance Bladder Cancer Trial
7M ago
PremiumCompany Announcements
Theralase’s Rutherrin Boosts Radiation Efficacy in Muscle Invasive Bladder Cancer Models
7M ago
PremiumCompany Announcements
Theralase Preclinical Data Backs Ruvidar–Interferon Combo for Bladder Cancer
7M ago
PremiumCompany AnnouncementsTheralase Preclinical Data Backs Ruvidar–Interferon Combo in Bladder Cancer
7M ago
Premium
Company Announcements
Theralase Bladder Cancer Data Heads to Major Urology Congress as Regulatory Plans Advance
8M ago
Premium
Company Announcements
Theralase Bladder Cancer Data to Headline 2026 European Urology Congress
8M ago
PremiumCompany Announcements
Theralase Bladder Cancer Data to Debut at 2026 European Urology Congress
8M ago
PremiumCompany Announcements
Theralase Bladder Cancer Data Heads to Key Urology Conference as Regulatory Filings Near
8M ago
PremiumCompany Announcements
Theralase’s Bladder Cancer Therapy Exceeds Key Benchmarks in Phase II Trial
8M ago
PremiumCompany Announcements
Theralase Hits Key Enrollment Milestone in Phase II Bladder Cancer Trial
8M ago
Theralase and Ferring Launch Combination Trial for BCG-Unresponsive Bladder Cancer
PremiumCompany AnnouncementsTheralase and Ferring Launch Combination Trial for BCG-Unresponsive Bladder Cancer
9M ago
Theralase Raises C$1.3 Million to Advance Bladder Cancer Trial
Premium
Company Announcements
Theralase Raises C$1.3 Million to Advance Bladder Cancer Trial
9M ago
Theralase Launches Private Placement to Fund Cancer Research
Premium
Company Announcements
Theralase Launches Private Placement to Fund Cancer Research
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >